YDKG Q4 2012 Earnings EPS Misses Estimates Stock Edges Higher PSO Q4 2025 Earnings Modest EPS Beat Highlights Steady Execution Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss Meets Optimism in Gene Therapy Pipeline BRC Group Holdings RILYN Q1 2024 Earnings Net Loss of 171 per Share Reflects Ongoing Pressures STOK Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances QCLS Q4 2017 Earnings Massive EPS Miss Reflects Operational Challenges